Jarrow submits appeal to FDA over ‘incomplete’ response to NDI guidance FOIA request
Jarrow Formulas has submitted a formal appeal to the Food & Drug Administration objecting to its “incomplete response” to a Freedom of Information Act (FOIA) request about its controversial draft guidance on New Dietary Ingredients (NDIs).